Prima Biomed Announces Japanese Patent Grants for IMP321 in Cancer By: Benzinga via Benzinga May 01, 2016 at 20:02 PM EDT Prima BioMed Ltd (NASDAQ: PBMD) announces the granting of patent number 5908210 entitled "Use of Recombinant LAG-3 or the Derivatives ... Read More >>